Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure
- 30 November 1977
- journal article
- research article
- Published by Elsevier
- Vol. 40 (5) , 794-801
- https://doi.org/10.1016/0002-9149(77)90199-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Vasodilator therapy for chronic left ventricular failure.Circulation, 1976
- Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.Circulation, 1975
- Hemodynamic effects of nitroglycerin in acute myocardial infarction.Circulation, 1975
- Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.Circulation, 1975
- Intravenous nitroglycerin in acute myocardial infarction.Circulation, 1975
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart FailureCirculation, 1974
- Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular FailureCirculation, 1973
- The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human ForearmCirculation, 1965
- The Effects of Intravenous Apresoline (Hydralazine) on Cardiovascular and Renal Function in Patients with and without Congestive Heart FailureCirculation, 1956